| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
6 companies
Link William J Phd is a Director at LNSR, with reported holdings spanning 6 companies. Recent filings cover 1 purchase and 31 sales. Those positions are worth an estimated $7.5M at current prices.
Our model assigns Link William J Phd a below-average insider score of 37/100, based on 5 past trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -24.2%.
Link William J Phd's largest disclosed position is in TARS as Director, worth about $7.5M. The recent filings there lean toward selling, a net 122,562 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 12,500 | $78.38 | $979,744.41 | -11.7% | - | - | |
| Jun 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Director | Sell10b5-1 | 12,500 | $62.12 | $776,495.16 | -10.5% | +29.3% | - | |
| Mar 16, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Director | Sell10b5-1 | 12,500 | $68.79 | $859,818.70 | -9.7% | -10.2% | - | |
| Dec 15, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Director | Sell10b5-1 | 22,946 | $81.26 | $1,864,677.82 | -100% | -14.4% | - | |
| Sep 8, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Director | Sell | 27,116 | $57.00 | $1,545,612.00 | -15.9% | +44.5% | +53.3% | |
| Aug 12, 2024 | TARS Tarsus Pharmaceuticals, Inc. | Director | Sell | 35,000 | $26.08 | $912,960.92 | -100% | +87.3% | +96.0% | |
| Feb 1, 2024 | RXST Rxsight, Inc. | Director | Sell | 28,250 | $49.67 | $1,403,120.09 | -53.8% | +13.9% | -32.0% | |
| Aug 3, 2021 | RXST Rxsight, Inc. | Director, 10% Owner | Buy | 31,250 | $16.00 | $500,000.00 | +533.4% | -28.2% | -8.6% | |
| Dec 1, 2020 | GKOS Glaukos Corp | Director | Sale+OE | 50,000 | $67.97 | $3,398,322.44 | -76.4% | - | - | |
| Aug 21, 2019 | EW Edwards Lifesciences Corp | Director | Sell | 10,214 | $221.86 | $2,266,108.56 | -68.4% | - | - |